Concepedia

Arndt Vogel

AV

Statistics

Publications

15

Citations

2.1K

H-Index

12

Active since

2021

Affiliations

Medizinische Hochschule Hannover(Current)

Hôpital Beaujon

Assistance Publique – Hôpitaux de Paris

Kindai University

Nanjing General Hospital of Nanjing Military Command

Arndt Vogel is an author at Medizinische Hochschule Hannover specializing in oncology, medicine, and pharmacotherapy.

Publications per year

2021–2025

15

Publications

15

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

Do‐Youn Oh, Aiwu Ruth He, Shukui Qin et al. · NEJM Evidence · 2022 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +14

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Do‐Youn Oh, Aiwu Ruth He, Mohamed Bouattour et al. · The Lancet. Gastroenterology & hepatology · 2024 · 254 citations · Full text

Medicine, Oncology, Pharmacology +11

Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Arndt Vogel, S.L. Chan, Laura A. Dawson et al. · Annals of Oncology · 2025 · 192 citations

Medicine, Oncology, Surgery +14

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

Philipp K. Haber, Florian Castet, Miguel Torres‐Martín et al. · Gastroenterology · 2022 · 146 citations · Full text

Medicine, Cancer Biology, Oncology +16

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib

Masatoshi Kudo, Richard S. Finn, Julien Edeline et al. · European Journal of Cancer · 2022 · 129 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

1–5 of 15